Literature DB >> 18391209

Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo.

O Kalyuzhniy1, N C Di Paolo, M Silvestry, S E Hofherr, M A Barry, P L Stewart, D M Shayakhmetov.   

Abstract

Human species C adenovirus serotype 5 (Ad5) is the most common viral vector used in clinical studies worldwide. Ad5 vectors infect liver cells in vivo with high efficiency via a poorly defined mechanism, which involves virus binding to vitamin K-dependent blood coagulation factors. Here, we report that the major Ad5 capsid protein, hexon, binds human coagulation factor X (FX) with an affinity of 229 pM. This affinity is 40-fold stronger than the reported affinity of Ad5 fiber for the cellular receptor coxsackievirus and adenovirus receptor, CAR. Cryoelectron microscopy and single-particle image reconstruction revealed that the FX attachment site is localized to the central depression at the top of the hexon trimer. Hexon-mutated virus bearing a large insertion in hexon showed markedly reduced FX binding in vitro and failed to deliver a transgene to hepatocytes in vivo. This study describes the mechanism of FX binding to Ad5 and demonstrates the critical role of hexon for virus infection of hepatocytes in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391209      PMCID: PMC2291105          DOI: 10.1073/pnas.0711757105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors.

Authors:  R Alemany; D T Curiel
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

Review 3.  Progress and problems with the use of viral vectors for gene therapy.

Authors:  Clare E Thomas; Anja Ehrhardt; Mark A Kay
Journal:  Nat Rev Genet       Date:  2003-05       Impact factor: 53.242

4.  Adenovirus infection: taking the back roads to viral entry.

Authors:  Danika L Goosney; Glen R Nemerow
Journal:  Curr Biol       Date:  2003-02-04       Impact factor: 10.834

Review 5.  Ligand-directed targeting of genes to the site of disease.

Authors:  Thomas J Wickham
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

6.  Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape.

Authors:  Robert W Walters; Paul Freimuth; Thomas O Moninger; Ingrid Ganske; Joseph Zabner; Michael J Welsh
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

7.  Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo.

Authors:  Nelson C Di Paolo; Oleksandr Kalyuzhniy; Dmitry M Shayakhmetov
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.

Authors:  Theodore Smith; Neeraja Idamakanti; Helen Kylefjord; Michele Rollence; Laura King; Michele Kaloss; Michael Kaleko; Susan C Stevenson
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

9.  Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.

Authors:  John W Schoggins; Jason G D Gall; Erik Falck-Pedersen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 10.  Structural evidence for common functions and ancestry of the reovirus and adenovirus attachment proteins.

Authors:  Thilo Stehle; Terence S Dermody
Journal:  Rev Med Virol       Date:  2003 Mar-Apr       Impact factor: 6.989

View more
  179 in total

1.  Construction of metabolically biotinylated adenovirus with deleted fiber knob as targeting vector.

Authors:  Yanzheng Liu; Philippe Valadon; Jan E Schnitzer
Journal:  Virol J       Date:  2010-11-12       Impact factor: 4.099

Review 2.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

3.  Targeting adenoviruses with factor x-single-chain antibody fusion proteins.

Authors:  Christopher Y Chen; Shannon M May; Michael A Barry
Journal:  Hum Gene Ther       Date:  2010-06       Impact factor: 5.695

4.  Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

Authors:  Lena J Gamble; Anton V Borovjagin; Qiana L Matthews
Journal:  Exp Ther Med       Date:  2010-03       Impact factor: 2.447

5.  Usage of integrin and heparan sulfate as receptors for mouse adenovirus type 1.

Authors:  Sharmila Raman; Tien-Huei Hsu; Shanna L Ashley; Katherine R Spindler
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

6.  Circulating antibodies and macrophages as modulators of adenovirus pharmacology.

Authors:  Reeti Khare; Matthew L Hillestad; Zhili Xu; Andrew P Byrnes; Michael A Barry
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

7.  Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.

Authors:  Sergey A Kaliberov; Lyudmila N Kaliberova; Zhi Hong Lu; Meredith A Preuss; Justin A Barnes; Cecil R Stockard; William E Grizzle; Jeffrey M Arbeit; David T Curiel
Journal:  Virology       Date:  2013-10-15       Impact factor: 3.616

8.  Detection of infectious adenoviruses in environmental waters by fluorescence-activated cell sorting assay.

Authors:  Dan Li; Miao He; Sunny C Jiang
Journal:  Appl Environ Microbiol       Date:  2010-01-15       Impact factor: 4.792

9.  Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.

Authors:  Jenny A Greig; Suzanne Mk Buckley; Simon N Waddington; Alan L Parker; David Bhella; Rebecca Pink; Ahad A Rahim; Takashi Morita; Stuart A Nicklin; John H McVey; Andrew H Baker
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

Review 10.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.